TY - JOUR
T1 - Integrated outpatient treatment of opioid use disorder and injection-related infections
T2 - A description of a new care model
AU - Fanucchi, Laura C.
AU - Walsh, Sharon L.
AU - Thornton, Alice C.
AU - Lofwall, Michelle R.
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/11
Y1 - 2019/11
N2 - Persons with opioid use disorder (OUD) hospitalized with severe, injection-related infections (SIRI) are frequently hospitalized for the duration of IV antibiotic treatment due to concerns regarding their eligibility for outpatient parenteral antimicrobial therapy (OPAT), which is the standard of care for prolonged IV antibiotic courses for patients without drug use. As part of a pilot study, a novel, integrated care model was developed where patients with OUD and SIRI receive addiction consultation and buprenorphine induction while hospitalized, followed by ongoing management in an outpatient clinic that combines office-based opioid treatment with buprenorphine pharmacotherapy and counseling services with OPAT. Through three illustrative case vignettes the outpatient model is described along with challenges, lessons learned and future directions.
AB - Persons with opioid use disorder (OUD) hospitalized with severe, injection-related infections (SIRI) are frequently hospitalized for the duration of IV antibiotic treatment due to concerns regarding their eligibility for outpatient parenteral antimicrobial therapy (OPAT), which is the standard of care for prolonged IV antibiotic courses for patients without drug use. As part of a pilot study, a novel, integrated care model was developed where patients with OUD and SIRI receive addiction consultation and buprenorphine induction while hospitalized, followed by ongoing management in an outpatient clinic that combines office-based opioid treatment with buprenorphine pharmacotherapy and counseling services with OPAT. Through three illustrative case vignettes the outpatient model is described along with challenges, lessons learned and future directions.
KW - Buprenorphine
KW - Endocarditis
KW - Intravenous
KW - Opiate-related disorders
KW - Substance abuse
KW - Vascular access devices
UR - http://www.scopus.com/inward/record.url?scp=85067968525&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067968525&partnerID=8YFLogxK
U2 - 10.1016/j.ypmed.2019.105760
DO - 10.1016/j.ypmed.2019.105760
M3 - Article
C2 - 31251946
AN - SCOPUS:85067968525
SN - 0091-7435
VL - 128
JO - Preventive Medicine
JF - Preventive Medicine
M1 - 105760
ER -